The role of interleukin-10 in lung transplantation

被引:34
作者
Boehler, A [1 ]
机构
[1] Univ Zurich Hosp, Div Pulm Med, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Lung Transplant Program, CH-8091 Zurich, Switzerland
关键词
IL-10; lung transplantation; infection; ischemia-reperfusion injury; acute rejection; chronic rejection; bronchiolitis obliterans;
D O I
10.1016/S0966-3274(02)00045-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-10 (IL-10) is a pleiotropic cytokine and its main function is to limit and terminate inflammatory responses. Lung transplantation is a relatively young clinical field compared to the transplantation of other solid organs and long-term survival is still limited. Complications after lung transplantation include ischemia-reperfusion injury immediately after transplantation, acute rejection and infection within the first year after transplantation and chronic allograft dysfunction in form of bronchiolitis obliterans thereafter. In the setting of lung transplantation two key functions of IL-10 might be of interest: (1) the inhibition of inflammatory immune responses;, and (2) the inhibition of T-cell mediated immune responses. In animal models, it has been shown that exogenous IL-10 is able to prevent posuransplant ischemia-reperfusion injury as well as to decrease acute rejection. It was also effective in preventing airway obliteration in an animal model of posttransplant bronchiolitis obliterans. Beneficial effects of IL-10 may be found early and late after lung transplantation. Location of IL-10 expression as well as the timing of administration seems to be important for the desired effects. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:121 / 124
页数:4
相关论文
共 37 条
[1]   Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans [J].
Boehler, A ;
Chamberlain, D ;
Kesten, S ;
Slutsky, AS ;
Liu, MY ;
Keshavjee, S .
TRANSPLANTATION, 1997, 64 (02) :311-317
[2]   Upregulation of T-helper 1 cytokines and chemokine expression in post-transplant airway obliteration [J].
Boehler, A ;
Bai, XH ;
Liu, MY ;
Cassivi, S ;
Chamberlain, D ;
Slutsky, AS ;
Keshavjee, S .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (06) :1910-1917
[3]   Adenovirus-mediated interleukin-10 gene transfer inhibits post-transplant fibrous airway obliteration in an animal model of bronchiolitis obliterans [J].
Boehler, A ;
Chamberlain, D ;
Xing, Z ;
Slutsky, AS ;
Jordana, M ;
Gauldie, J ;
Liu, M ;
Keshavjee, S .
HUMAN GENE THERAPY, 1998, 9 (04) :541-551
[4]   Interleukin-10 in non-Hodgkin's lymphoma [J].
Cortes, J ;
Kurzrock, R .
LEUKEMIA & LYMPHOMA, 1997, 26 (3-4) :251-259
[5]   Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses [J].
Debruyne, LA ;
Li, K ;
Chan, SY ;
Qin, L ;
Bishop, DK ;
Bromberg, JS .
GENE THERAPY, 1998, 5 (08) :1079-1087
[6]   Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia-reperfusion injury [J].
Engles, RE ;
Huber, TS ;
Zander, DS ;
Hess, PJ ;
Welborn, MB ;
Moldawer, LL ;
Seeger, JM .
JOURNAL OF SURGICAL RESEARCH, 1997, 69 (02) :425-428
[7]  
FINBLOOM DS, 1995, J IMMUNOL, V155, P1079
[8]  
Fischer S., 2001, Journal of Heart and Lung Transplantation, V20, P152, DOI 10.1016/S1053-2498(00)00263-1
[9]   Interleukin-10 (IL-10) augments allograft arterial disease - Paradoxical effects of IL-10 in vivo [J].
Furukawa, Y ;
Becker, G ;
Stinn, JL ;
Shimizu, K ;
Libby, P ;
Mitchell, RN .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) :1929-1939
[10]   INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA [J].
GERARD, C ;
BRUYNS, C ;
MARCHANT, A ;
ABRAMOWICZ, D ;
VANDENABEELE, P ;
DELVAUX, A ;
FIERS, W ;
GOLDMAN, M ;
VELU, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :547-550